MedPath

Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Phase 3
Active, not recruiting
Conditions
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Interventions
Drug: mFOLFOX6
Drug: Placebo
Registration Number
NCT05052801
Lead Sponsor
Amgen
Brief Summary

The main objective of this study is to compare efficacy of bemarituzumab combined with oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) (mFOLFOX6) to placebo plus mFOLFOX6 as assessed by overall survival (OS) in participants with FGFR2b ≥10% 2+/3+ tumor cell staining (FGFR2b ≥10% 2+/3+TC)

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
547
Inclusion Criteria
  • Adults with histologically documented unresectable, locally advanced or metastatic gastric or gastroesophageal junction cancer not amenable to curative therapy

  • Fibroblast growth factor receptor 2b (FGFR2b) ≥10% 2+/3+ tumor cell staining as determined by centrally performed immunohistochemistry (IHC) testing, based on tumor sample either archival (obtained within 6 months/180 days prior to signing pre-screening informed consent) or a fresh biopsy

  • Eastern Cooperative Oncology Group (ECOG) less than or equal to 1

  • Measurable disease or non-measurable, but evaluable disease, according to Response Evaluation Criteria in Solid Tumors (RECIST) V 1.1

  • Participant has no contraindications to mFOLFOX6 chemotherapy

  • Adequate organ and bone marrow function:

    • absolute neutrophil count greater than or equal to 1.5 times 10^9/L
    • platelet count greater than or equal to 100 times 10^9/L
    • hemoglobin ≥ 9 g/dL without red blood cell (RBC) transfusion within 7 days prior to the first dose of study treatment
    • aspartate aminotransferase (AST) and alanine aminotransferase (ALT) less than 3 times the upper limit of normal (ULN) (or less than 5 times ULN if liver involvement). Total bilirubin less than 1.5 times ULN (or less than 2 times ULN if liver involvement); with the exception of participants with Gilbert's disease)
    • calculated or measured creatinine clearance (CrCl) of ≥ 30 mL/minute calculated using the formula of Cockcroft and Gault ([140 - Age]) × Mass [kg]/[72 × Creatinine mg/dL]) (x 0.85 if female)
    • international normalized ratio (INR) or prothrombin time (PT) less than 1.5 times ULN except for participants receiving anticoagulation, who must be on a stable dose of anticoagulant therapy for 6 weeks prior to enrollment
Exclusion Criteria
  • Prior treatment for metastatic or unresectable disease (Note: prior adjuvant, neo-adjuvant, and peri-operative therapy is allowed if completed more than 6 months prior to first dose of study treatment)
  • Prior treatment with any selective inhibitor of fibroblast growth factor - fibroblast growth factor receptor (FGF-FGFR) pathway
  • Known human epidermal growth factor receptor 2 (HER2) positive
  • Untreated or symptomatic central nervous system (CNS) disease or brain metastases
  • Peripheral sensory neuropathy greater than or equal to Grade 2
  • Clinically significant cardiac disease
  • Other malignancy within the last 2 years (exceptions for definitively treated disease)
  • Chronic or systemic ophthalmological disorders
  • Major surgery or other investigational study within 28 days prior to first dose of study treatment
  • Palliative radiotherapy within 14 days prior to the first dose of study treatment
  • Evidence of or recent history (within 6 months) of corneal defects, corneal ulcerations, keratitis, or keratoconus, history of corneal transplant, or other known abnormalities of the cornea that may pose an increased risk of developing a corneal ulcer.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Bemarituzumab with mFOLFOX6Bemarituzumab-
Bemarituzumab with mFOLFOX6mFOLFOX6-
Placebo with mFOLFOX6mFOLFOX6-
Placebo with mFOLFOX6Placebo-
Primary Outcome Measures
NameTimeMethod
Overall SurvivalUp to approximately 3.5 years

Overall survival in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Secondary Outcome Measures
NameTimeMethod
Progression-free Survival (PFS)Up to approximately 3.5 years

PFS in all randomized participants

Objective Response Rate (ORR)Up to approximately 3.5 years

ORR in all randomized participants

Mean Subjective Score in European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30)Up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Change from Baseline Score in European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30)Baseline up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Stomach Cancer Related Symptom Mean Subjective Score as Measured by European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Stomach (EORTC-QLQ-STO22)Up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Mean Subjective Score in Visual Analogue Scale (VAS) as Measured by the EuroQol 5-dimensional 5-levels (EQ-5D-5L)Up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Maximum Observed Concentration (Cmax) of Bemarituzumab in Combination with mFOLFOX6 in PlasmaDay 1 up to approximately 3.5 years
Observed Concentration at the End of a Dose Interval (Ctrough) of Bemarituzumab in Combination with mFOLFOX6 in PlasmaDay 1 up to approximately 3.5 years
Disease Control RateUp to approximately 3.5 years

Disease Control Rate in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Number of Participants who Experience a Treatment-emergent Adverse Event (TEAE)Up to approximately 3.5 years

Any clinically significant changes in vital signs, visual acuity, and clinical laboratory tests after first dose will be recorded as TEAEs.

Overall SurvivalUp to approximately 3.5 years

Overall survival in all randomized participants

Duration of Response (DOR)Up to approximately 3.5 years

DOR in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Change from Baseline in Stomach Cancer Related Symptom Score as Measured by European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Stomach (EORTC-QLQ-STO22)Baseline up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Time to Deterioration in Physical Function Score as Measured by a Subscale of European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30)Day 1 up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Change from Baseline of Visual Analogue Scale (VAS) as Measured by the EuroQol 5-dimensional 5-levels (EQ-5D-5L)Baseline up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Time to Deterioration in Stomach Cancer Related Symptom Score as Measured by European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Stomach (EORTC-QLQ-STO22)Up to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Time to Deterioration in European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) ScoreUp to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Time to Deterioration in Visual Analogue Scale (VAS) as Measured by the EuroQol 5-dimensional 5-levels (EQ-5D-5L) ScoreUp to approximately 3.5 years

Measured in FGFR2b ≥ 10% 2+/3+ tumor cell staining participants

Number of Participants with an Anti-bemarituzumab Antibody FormationDay 1 up to approximately 3.5 years

Trial Locations

Locations (299)

251 General Airforce Hospital

🇬🇷

Athens, Greece

General Hospital of Athens Laiko

🇬🇷

Athens, Greece

Evgenidio Hospital I Agia Trias

🇬🇷

Athens, Greece

Metropolitan Hospital

🇬🇷

Athens, Greece

Szpitale Pomorskie Spzoo

🇵🇱

Gdynia, Poland

Szpital Kliniczny Ministerstwa Spraw Wewnetrznych i Administracji

🇵🇱

Olsztyn, Poland

Szpital Wojewodzki imienia Mikolaja Kopernika w Koszalinie

🇵🇱

Koszalin, Poland

Wojewodzki Szpital im Sw Ojca Pio w Przemyslu

🇵🇱

Przemysl, Poland

Hospital Provincial del Centenario

🇦🇷

Rosario, Santa Fe, Argentina

Lietuvos sveikatos mokslu universiteto ligonine viesoji istaiga Kauno klinikos

🇱🇹

Kaunas, Lithuania

Investigación Biomédica para el Desarrollo de Fármacos

🇲🇽

Aguascalientes, Mexico

Institutul Regional de Oncologie Iasi

🇷🇴

Iasi, Romania

National Cancer Centre Singapore

🇸🇬

Singapore, Singapore

Unidade Local de Saude de Entre Douro e Vouga, EPE - Hospital de Sao Sebastiao

🇵🇹

Santa Maria da Feira, Portugal

Ovidius Clinical Hospital

🇷🇴

Ovidiu, Romania

Sarawak General Hospital

🇲🇾

Kuching, Sarawak, Malaysia

Hospital Civil de Guadalajara Fray Antonio Alcalde

🇲🇽

Guadalajara, Jalisco, Mexico

Rajavithi Hospital

🇹🇭

Bangkok, Thailand

Tri-Service General Hospital

🇨🇳

Taipei, Taiwan

University Malaya Medical Centre

🇲🇾

Kuala Lumpur, Wilayah Persekutuan, Malaysia

China Medical University Hospital

🇨🇳

Taichung, Taiwan

King Chulalongkorn Memorial Hospital

🇹🇭

Bangkok, Thailand

Kaohsiung Medical University Chung-Ho Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Ramathibodi Hospital

🇹🇭

Bangkok, Thailand

National Cheng Kung University Hospital

🇨🇳

Tainan, Taiwan

Alaska Oncology and Hematology

🇺🇸

Anchorage, Alaska, United States

The Ottawa Hospital Cancer Centre

🇨🇦

Ottawa, Ontario, Canada

University Multiprofile Hospital for Active Treatment Dr Georgi Stranski EAD

🇧🇬

Pleven, Bulgaria

Centro de Pesquisa e Ensino em Oncologia de Santa Catarina

🇧🇷

Florianopolis, Santa Catarina, Brazil

Instituto de Ensino e Pesquisa Sao Lucas Iep Sao Lucas

🇧🇷

Santo Andre, São Paulo, Brazil

Centro de Estudios Clinicos SAGA Spa

🇨🇱

Santiago, Chile

Multiprofile Hospital for Active Treatment Park Hospital EOOD

🇧🇬

Branipole Village, Bulgaria

Mayo Clinic Florida

🇺🇸

Jacksonville, Florida, United States

Healthier Hematology and Oncology Excelsior Integrated Medical Group

🇺🇸

Brooklyn, New York, United States

Cross Cancer Institute

🇨🇦

Edmonton, Alberta, Canada

Oncosite Centro de Pesquisa Clinica Em Oncologia Ltda

🇧🇷

Ijui, Rio Grande Do Sul, Brazil

Universitair Ziekenhuis Gent

🇧🇪

Gent, Belgium

Clinica CIDO

🇨🇱

Temuco, Cautín, Chile

Hospital Privado Universitario de Cordoba

🇦🇷

Cordoba, Córdoba, Argentina

White Plains Hospital Center for Cancer Care

🇺🇸

White Plains, New York, United States

Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

Centro de Estudios Clinicos e Investigaciones Medicas CeCim

🇨🇱

Santiago, Chile

Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda EAD

🇧🇬

Sofia, Bulgaria

Instituto Alexander Fleming

🇦🇷

Caba, Buenos Aires, Argentina

Hospital Nove de Julho - dasa

🇧🇷

São Paulo, Brazil

Levine Cancer Institute University

🇺🇸

Charlotte, North Carolina, United States

The Oncology Institute Clinical Research

🇺🇸

Cerritos, California, United States

Avera Cancer Institute

🇺🇸

Sioux Falls, South Dakota, United States

Universitair Ziekenhuis Antwerpen

🇧🇪

Edegem, Belgium

Medical Oncology Associates, PS

🇺🇸

Spokane, Washington, United States

Centro de Oncologia Mackenzie

🇧🇷

Curitiba, Paraná, Brazil

Hospital Britanico de Buenos Aires

🇦🇷

Buenos Aires, Argentina

Sociedad de Beneficencia Hospital Italiano

🇦🇷

Cordoba, Córdoba, Argentina

University Multiprofile Hospital for Active Treatment Pulmed OOD

🇧🇬

Plovdiv, Bulgaria

North Estonia Medical Centre Foundation

🇪🇪

Tallinn, Estonia

Institucion Prestadora de Servicios de Salud Sociedad Médica Rionegro SA Somer SA

🇨🇴

Rionegro, Antioquia, Colombia

Fujian Medical University Union Hospital

🇨🇳

Fuzhou, Fujian, China

Fakultni Thomayerova nemocnice

🇨🇿

Praha 4, Czechia

Instituto Cancerologico de Narino Ltda

🇨🇴

Pasto, Colombia

Linfen Central Hospital

🇨🇳

Linfen, Shanxi, China

Centre Hospitalier Universitaire Amiens Picardie - Hopital Sud

🇫🇷

Amiens Cedex 1, France

Hôpital Européen Georges Pompidou

🇫🇷

Paris, France

Institut Mutualiste Montsouris

🇫🇷

Paris Cedex 14, France

Sainte Catherine - Institut du Cancer d Avignon

🇫🇷

Avignon cedex 9, France

Centre Hospitalier Universitaire de Reims - Hôpital Robert Debré

🇫🇷

Reims Cedex, France

St James Hospital

🇮🇪

Dublin, Ireland

Agios Savvas Anticancer Hospital

🇬🇷

Athens, Greece

Azienda Ospedaliera di Rilievo Nazionale e Alta Specializzazione Garibaldi Nesima

🇮🇹

Catania, Italy

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

🇮🇹

Milano, Italy

Azienda Unita Saniataria Locale IRCCS di Reggio Emilia

🇮🇹

Reggio Emilia, Italy

Institut de cancerologie Strasbourg Europe

🇫🇷

Strasbourg cedex, France

Sir Run Run Shaw Hospital Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

University Hospital of Patras

🇬🇷

Patra, Greece

Bioclinic of Thessaloniki

🇬🇷

Thessaloniki, Greece

Assuta Medical Center

🇮🇱

Jerusalem, Israel

Borsod-Abauj-Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktatokorhaz

🇭🇺

Miskolc, Hungary

Sociedad de Oncologia y Hematologia del Cesar

🇨🇴

Valledupar, Cesar, Colombia

Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz Nyiregyhazi Josa Andras Tagkorhaz

🇭🇺

Nyiregyhaza, Hungary

Centre Hospitalier Régional Universitaire de Besançon, Hôpital Jean Minjoz

🇫🇷

Besançon, France

Tolna Varmegyei Balassa Janos Korhaz

🇭🇺

Szekszard, Hungary

Vseobecna fakultni nemocnice v Praze

🇨🇿

Praha 2, Czechia

Centre Hospitalier Universitaire de Brest - Cavale Blanche

🇫🇷

Brest Cedex, France

IRCCS Istituto Clinico Humanitas

🇮🇹

Rozzano MI, Italy

Nagoya University Hospital

🇯🇵

Nagoya-shi, Aichi, Japan

Hadassah Ein-Kerem Medical Center

🇮🇱

Jerusalem, Israel

Meir Medical Center

🇮🇱

Kfar Saba, Israel

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Dong-A University Hospital

🇰🇷

Busan, Korea, Republic of

Masarykuv onkologicky ustav

🇨🇿

Brno, Czechia

St Vincents University Hospital

🇮🇪

Dublin 4, Ireland

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

Azienda Ospedaliero Universitaria di Cagliari Policlinico Duilio Casula

🇮🇹

Monserrato CA, Italy

Azienda Ospedaliera Ordine Mauriziano di Torino

🇮🇹

Torino, Italy

Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center

🇯🇵

Yokohama-shi, Kanagawa, Japan

Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktatokorhaz

🇭🇺

Gyor, Hungary

Centre Hospitalier Universitaire Nord de Saint Etienne - Hôpital Nord

🇫🇷

Saint Priest en Jarez, France

National Hospital Organization Kyushu Cancer Center

🇯🇵

Fukuoka-shi, Fukuoka, Japan

University Hospital of Larissa

🇬🇷

Larissa, Greece

Istituto Ospedaliero Fondazione Poliambulanza

🇮🇹

Brescia, Italy

Chiba Cancer Center

🇯🇵

Chiba-shi, Chiba, Japan

Niigata Cancer Center Hospital

🇯🇵

Niigata-shi, Niigata, Japan

Kangbuk Samsung Hospital

🇰🇷

Seoul, Korea, Republic of

Bekes Varmegyei Kozponti Korhaz Pandy Kalman Tagkorhaz

🇭🇺

Gyula, Hungary

The Catholic University of Korea Incheon St Marys Hospital

🇰🇷

Incheon, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Keio University Hospital

🇯🇵

Shinjuku-ku, Tokyo, Japan

Aichi Cancer Center

🇯🇵

Nagoya-shi, Aichi, Japan

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

The Cancer Institute Hospital of Japanese Foundation for Cancer Research

🇯🇵

Koto-ku, Tokyo, Japan

Pauls Stradins Clinical University Hospital

🇱🇻

Riga, Latvia

Trials In Medicine SC

🇲🇽

Mexico, Mexico

National Cancer Center

🇰🇷

Goyang-si Gyeonggi-do, Korea, Republic of

Kyungpook National University Chilgok Hospital

🇰🇷

Daegu, Korea, Republic of

Centro de Investigacion Clinica Trujillo Eirl

🇵🇪

Trujillo, La Libertad, Peru

Centro Medico Monte Carmelo

🇵🇪

Arequipa, Peru

Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio

🇵🇹

Porto, Portugal

Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE

🇵🇹

Porto, Portugal

SC Medisprof SRL

🇷🇴

Cluj-Napoca, Romania

SPZOZ Opolskie Centrum Onkologii imienia prof Tadeusza Koszarowskiego w Opolu

🇵🇱

Opole, Poland

Investigacion Biomedica para el Desarrollo de Farmacos SA de CV

🇲🇽

Zapopan, Jalisco, Mexico

Vilnius University Hospital Santaros Clinic Public Institution

🇱🇹

Vilnius, Lithuania

Hospital Kuala Lumpur

🇲🇾

Kuala Lumpur, Wilayah Persekutuan, Malaysia

Centro Oncologico Internacional

🇲🇽

Tijuana, Baja California Norte, Mexico

Centrum Onkologii im prof Franciszka Lukaszczyka

🇵🇱

Bydgoszcz, Poland

Karolinska Universitetssjukhuset Huddinge

🇸🇪

Stockholm, Sweden

Norrlands Universitetssjukhus

🇸🇪

Umea, Sweden

The Oncology Centre

🇿🇦

Durban, South Africa

Instituto Peruano de Oncologia y Radioterapia

🇵🇪

San Isidro, Lima, Peru

Oncosalud

🇵🇪

Lima, Peru

Unidade Local de Saude do Alto Ave, EPE

🇵🇹

Guimaraes, Portugal

Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria

🇵🇹

Lisboa, Portugal

Spitalul Judetean de Urgenta Dr Constantin Opris Baia Mare

🇷🇴

Baia Mare, Romania

Oslo University Hospital

🇳🇴

Oslo, Norway

Unidade Local de Saude de Coimbra, EPE

🇵🇹

Coimbra, Portugal

Unidade Local de Saude de Sao Joao, EPE - Hospital de Sao Joao

🇵🇹

Porto, Portugal

Institutul Clinic Fundeni

🇷🇴

Bucharest, Romania

Institutul Oncologic Prof Dr Alexandru Trestioreanu Bucuresti

🇷🇴

Bucuresti, Romania

Hacettepe Universitesi Tip Fakultesi Hastanesi

🇹🇷

Ankara, Turkey

Siriraj Hospital

🇹🇭

Bangkok, Thailand

Baskent Universitesi Adana Doktor Turgut Noyan Uygulama ve Arastirma Merkezi

🇹🇷

Adana, Turkey

Rigshospitalet

🇩🇰

Copenhagen, Denmark

The First Affiliated Hospital of Anhui Medical University

🇨🇳

Hefei, Anhui, China

Anhui Provincial Cancer Hospital

🇨🇳

Hefei, Anhui, China

Cancer Hospital of Chinese Academy of Medical Sciences

🇨🇳

Beijing, Beijing, China

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

Lanzhou University Second Hospital

🇨🇳

Lanzhou, Gansu, China

Gansu Wuwei Tumour Hospital

🇨🇳

Wuwei, Gansu, China

Cancer Hospital of Shantou University Medical College

🇨🇳

Shantou, Guangdong, China

The First Affiliated Hospital of Hainan Medical University

🇨🇳

Haikou, Hainan, China

Fourth Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of ScienceandTechnology

🇨🇳

Wuhan, Hebei, China

Harbin Medical University Cancer Hospital

🇨🇳

Harbin, Heilongjiang, China

Anyang Cancer Hospital

🇨🇳

Anyang, Henan, China

The First Affiliated Hospital of Henan University of science and Technology

🇨🇳

Luoyang, Henan, China

The First Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

The First Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, Jiangxi, China

Henan Cancer Hospital

🇨🇳

Zhengzhou, Henan, China

Taihe Hospital Affiliated Hospital of Hubei University of Medicine

🇨🇳

Shiyan, Hubei, China

Hubei Cancer Hospital

🇨🇳

Wuhan City, Hubei, China

The First Hospital of China Medical University

🇨🇳

Shenyang, Liaoning, China

Zhongshan Hospital Fudan University

🇨🇳

Shanghai, Shanghai, China

Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

Affiliated Hospital of Jiangnan University

🇨🇳

Wuxi, Jiangsu, China

China-Japan Union Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

Hunan Cancer Hospital

🇨🇳

Changsha, Hunan, China

The Second Affiliated Hospital of Soochow University

🇨🇳

Suzhou, Jiangsu, China

The Affiliated Hospital of Xuzhou Medical University

🇨🇳

Xuzhou, Jiangsu, China

Nanjing First Hospital

🇨🇳

Nanjing, Jiangsu, China

The First Hospital of Jilin University

🇨🇳

Changchun, Jilin, China

The First Affiliated Hospital of Jinzhou Medical University

🇨🇳

Jinzhou, Liaoning, China

The First Affiliated Hospital of Xi an Jiaotong University

🇨🇳

XI An, Shaanxi, China

Jinan Central Hospital

🇨🇳

Jinan, Shandong, China

The Affiliated Hospital of Qingdao University

🇨🇳

Qingdao, Shandong, China

Fudan University Shanghai Cancer Center

🇨🇳

Shanghai, Shanghai, China

Liaoning Cancer Hospital

🇨🇳

Shenyang, Liaoning, China

The Affiliated Cancer Hospital of Shandong First Medical University

🇨🇳

Jinan, Shandong, China

Beijing Cancer Hospital

🇨🇳

Beijing, China

Taizhou Hospital of Zhejiang Province

🇨🇳

Linhai, Zhejiang, China

The First Affiliate Hospital of Ningbo University

🇨🇳

Ningbo, Zhejiang, China

Peoples Hospital of Quzhou

🇨🇳

Quzhou, Zhejiang, China

Tianjin Medical University Cancer institute and hospital

🇨🇳

Tianjin, China

Lishui Municipal central Hospital

🇨🇳

Lishui, Zhejiang, China

Changzhi Peoples Hospital

🇨🇳

Changzhi, Shanxi, China

Shanxi Province Cancer Hospital

🇨🇳

Taiyuan, Shanxi, China

Sichuan Cancer Hospital

🇨🇳

Chengdu, Sichuan, China

Azienda Ospedaliera Cardinale Giovanni Panico

🇮🇹

Tricase, Italy

Azienda Sanitaria Universitaria Friuli Centrale Presidio Ospedaliero Santa Maria della Misericordia

🇮🇹

Udine, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

🇮🇹

Roma, Italy

Instituto Brasileiro de Controle do Cancer Ibcc

🇧🇷

São Paulo, Brazil

Centre Hospitalier Universitaire de Clermont Ferrand, Hôpital Estaing

🇫🇷

Clermont-Ferrand cedex 1, France

Centre Leon Berard

🇫🇷

Lyon cedex 8, France

Hokkaido University Hospital

🇯🇵

Sapporo, Hokkaido, Japan

National Cancer Center Hospital East

🇯🇵

Kashiwa-shi, Chiba, Japan

Hyogo Cancer Center

🇯🇵

Akashi-shi, Hyogo, Japan

Yokohama City University Medical Center

🇯🇵

Yokohama-shi, Kanagawa, Japan

Kansai Medical University Hospital

🇯🇵

Hirakata-shi, Osaka, Japan

Kindai University Hospital

🇯🇵

Osakasayama-shi, Osaka, Japan

Saitama Cancer Center

🇯🇵

Kitaadachi-gun, Saitama, Japan

Shizuoka Cancer Center

🇯🇵

Sunto-gun, Shizuoka, Japan

Osaka University Hospital

🇯🇵

Suita-shi, Osaka, Japan

Steve Biko Academic Hospital

🇿🇦

Tshwane, South Africa

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

Specialized Hospital for Active Treatment of Oncology - Haskovo EOOD

🇧🇬

Haskovo, Bulgaria

Instituto Argentino de Diagnostico y Tratamiento IADT

🇦🇷

Buenos Aires, Argentina

Azienda Ospedaliera San Giovanni Addolorata

🇮🇹

Roma, Italy

National Hospital Organization Shikoku Cancer Center

🇯🇵

Matsuyama-shi, Ehime, Japan

Hospital Universitario Fundacion Favaloro

🇦🇷

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Exelsus Oncologia Clinica

🇦🇷

San Miguel de Tucuman, Tucuman, Argentina

Instituto Nacional de Cancer

🇧🇷

Rio de Janeiro, Brazil

Jewish General Hospital

🇨🇦

Montreal, Quebec, Canada

Multiprofile Hospital for Active Treatment Serdika EOOD

🇧🇬

Sofia, Bulgaria

James Lind Centro de Investigacion del Cancer

🇨🇱

Temuco, Cautín, Chile

The First Affiliated Hospital of Bengbu Medical College

🇨🇳

Bengbu, Anhui, China

Chongqing University Three Gorges Hospital

🇨🇳

Chongqing, Chongqing, China

The First Affiliated Hospital of Xiamen University

🇨🇳

Xiamen, Fujian, China

Sun Yat-sen University Cancer Center

🇨🇳

Guangzhou, Guangdong, China

Guangdong Provincial Peoples Hospital

🇨🇳

Guangzhou, Guangdong, China

Fakultni nemocnice Hradec Kralove

🇨🇿

Hradec Kralove, Czechia

Fakultni nemocnice Olomouc

🇨🇿

Olomouc, Czechia

Centre Hospitalier Régional Universitaire de Lille - Hôpital Claude Huriez

🇫🇷

Lille, France

Institut Gustave Roussy

🇫🇷

Villejuif, France

University Hospital of Heraklion

🇬🇷

Heraklion - Crete, Greece

Anticancer Hospital of Thessaloniki Theageneio

🇬🇷

Thessaloniki, Greece

Azienda Unita Sanitaria Locale LE Presidio Ospedaliero Vito Fazzi Polo Oncologico Giovanni Paolo II

🇮🇹

Lecce, Italy

Azienda Ospedaliera Universitaria Integrata di Verona Ospedale Civile Maggiore Borgo Trento

🇮🇹

Verona, Italy

Kobe City Medical Center General Hospital

🇯🇵

Kobe-shi, Hyogo, Japan

Gifu University Hospital

🇯🇵

Gifu-shi, Gifu, Japan

Ishikawa Prefectural Central Hospital

🇯🇵

Kanazawa-shi, Ishikawa, Japan

Kagawa University Hospital

🇯🇵

Kita-gun, Kagawa, Japan

Kyoto University Hospital

🇯🇵

Kyoto-shi, Kyoto, Japan

Osaka International Cancer Institute

🇯🇵

Osaka-shi, Osaka, Japan

Jeonbuk National University Hospital

🇰🇷

Jeonju-si, Jeollabuk-do, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

Severance Hospital Yonsei University Health System

🇰🇷

Seoul, Korea, Republic of

The Catholic University of Korea Seoul St Marys Hospital

🇰🇷

Seoul, Korea, Republic of

Viesoji istaiga Klaipedos universitetine ligonine

🇱🇹

Klaipeda, Lithuania

Nacionalinis vezio institutas

🇱🇹

Vilnius, Lithuania

Wielkopolskie Centrum Onkologii imienia Marii Sklodowskiej-Curie

🇵🇱

Poznan, Poland

Sandton Oncology Centre

🇿🇦

Gauteng, South Africa

Hospital Universitario Reina Sofia

🇪🇸

Cordoba, Andalucía, Spain

Netcare Milpark Hospital

🇿🇦

Johannesburg, South Africa

Hospital Universitario Miguel Servet

🇪🇸

Zaragoza, Aragón, Spain

Corporacio Sanitaria Parc Tauli

🇪🇸

Sabadell, Cataluña, Spain

Hospital Regional Universitario de Malaga

🇪🇸

Malaga, Andalucía, Spain

Hospital Universitario de Burgos

🇪🇸

Burgos, Castilla León, Spain

Hospital Clinic i Provincial de Barcelona

🇪🇸

Barcelona, Cataluña, Spain

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Cataluña, Spain

Hospital Universitari i Politecnic La Fe

🇪🇸

Valencia, Comunidad Valenciana, Spain

Hospital Donostia

🇪🇸

San Sebastian, País Vasco, Spain

Complexo Hospitalario Universitario de Ourense

🇪🇸

Ourense, Galicia, Spain

Hospital General Universitario Gregorio Marañon

🇪🇸

Madrid, Spain

Hospital Universitario Puerta de Hierro Majadahonda

🇪🇸

Madrid, Spain

Hospital General Universitario Jose Maria Morales Meseguer

🇪🇸

Murcia, Spain

Sahlgrenska Universitetssjukhuset

🇸🇪

Göteborg, Sweden

Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation

🇨🇳

Taoyuan, Taiwan

Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi

🇹🇷

Ankara, Turkey

Memorial Ankara Hastanesi

🇹🇷

Ankara, Turkey

Ankara Bilkent Sehir Hastanesi

🇹🇷

Ankara, Turkey

Antalya Egitim ve Arastirma Hastanesi

🇹🇷

Antalya, Turkey

Bezmialem Vakif Universitesi Hastanesi

🇹🇷

Istanbul, Turkey

Dicle Universitesi Tip Fakultesi

🇹🇷

Diyarbakir, Turkey

Istanbul Universitesi Cerrahpasa Tip Fakultesi

🇹🇷

Istanbul, Turkey

Kocaeli Universitesi Tip Fakultesi Hastanesi

🇹🇷

Kocaeli, Turkey

Goztepe Prof Dr Suleyman Yalcin Sehir Hastanesi

🇹🇷

Istanbul, Turkey

Kartal Dr Lutfi Kirdar Sehir Hastanesi

🇹🇷

Istanbul, Turkey

Izmir Ataturk Egitim ve Arastirma Hastanesi

🇹🇷

Izmir, Turkey

Sakarya Egitim ve Arastirma Hastanesi

🇹🇷

Sakarya, Turkey

Inonu Universitesi Turgut Ozal Tip Merkezi

🇹🇷

Malatya, Turkey

Ondokuz Mayis Universitesi Tip Fakultesi Hastanesi

🇹🇷

Samsun, Turkey

Van Yuzuncu Yil Universitesi Dursun Odabas Tip Merkezi

🇹🇷

Van, Turkey

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Inova Schar Cancer Institute

🇺🇸

Fairfax, Virginia, United States

Clinica de Oncologia Reichow

🇧🇷

Blumenau, Santa Catarina, Brazil

Mayo Clinic Rochester

🇺🇸

Rochester, Minnesota, United States

FirstHealth Cancer Center

🇺🇸

Pinehurst, North Carolina, United States

Mayo Clinic Arizona

🇺🇸

Phoenix, Arizona, United States

University of California Los Angeles

🇺🇸

Los Angeles, California, United States

Saint Francis Medical Group

🇺🇸

Indianapolis, Indiana, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

St John of God Murdoch Hospital

🇦🇺

Murdoch, Western Australia, Australia

Núcleo de Oncologia da Bahia

🇧🇷

Salvador, Bahia, Brazil

Liverpool Hospital

🇦🇺

Liverpool, New South Wales, Australia

Sunnybrook Research Institute Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

Christus Muguerza Clinica Vidriera

🇲🇽

Monterrey, Nuevo León, Mexico

Filios Alta Medicina sa de cv

🇲🇽

Monterrey, Nuevo León, Mexico

Kliniki Neuroradiochirurgii Spzoo Radom Centr Onkolo im Bohater Radomsk Czerwca -76 Szpital Specjal

🇵🇱

Radom, Poland

Biokinetica SA

🇵🇱

Jozefow, Poland

Centre Hospitalier Universitaire de Liege - Sart Tilman

🇧🇪

Liege, Belgium

Universitair Ziekenhuis Leuven - Campus Gasthuisberg

🇧🇪

Leuven, Belgium

Fundacion Cardiovascular de Colombia

🇨🇴

Bucaramanga, Santander, Colombia

The Cancer Center Union Hospital Tongji Medical College Huazhong University of Science and Tech

🇨🇳

Wuhan, Hubei, China

Shanghai General Hospital

🇨🇳

Shanghai, Shanghai, China

Shanghai East Hospital

🇨🇳

Shanghai, Shanghai, China

Ruijin Hospital Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

The First Affiliated Hospital Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

The Second Affiliated Hospital Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

Fujian Cancer Hospital

🇨🇳

Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath